Home > News > 84/The benefit of opportunistic screening at Know Your Pulse community-based events to identify people with undiagnosed AF in Oxfordshire & Warwickshire
Read Time: 2 mins

84/The benefit of opportunistic screening at Know Your Pulse community-based events to identify people with undiagnosed AF in Oxfordshire & Warwickshire

Published Online: September 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr84
Authors: T Lobban MBE (Presenting Author) - Arrhythmia Alliance, Chipping Norton; S Kempton -; Arrhythmia Alliance, Chipping Norton; N Breakwell - Arrhythmia Alliance, Chipping Norton
Quick Links:
Article Information

Summary: Arrhythmias affect more than two million people every year in the UK (NHS, 2018). Atrial Fibrillation (AF) is the most common cardiac arrhythmia, with over 1.5 million people diagnosed, however approximately 500,000 individuals remain undiagnosed, and at risk of suffering a life-threatening, debilitating AF-related stroke. It is paramount that these individuals are anticoagulated effectively to reduce their risk of such a stroke. The Arrhythmia Alliance (A-A) Know Your Pulse campaign was established in 2010 following a need for community-wide awareness and education of the importance of knowing your pulse rate and rhythm. In response to the need to identify the undiagnosed person with AF, the ‘Know Your Pulse’ campaign has undertaken opportunistic screening of people at all of its events, using manual pulse rhythm checks and mobile ECG technology.

Aims: To demonstrate the benefit of opportunistic screening at Know Your Pulse community-based events to identify people with undiagnosed AF within Warwickshire & Oxfordshire.

Methodology: Know Your Pulse (KYP) events are set up in high-footfall locations in towns/cities across the UK, publicised through local media, pharmacies and surgeries, where agreed. Attendees were offered a 30 second mobile ECG pulse check, using the AliveCor Kardia mobile single-lead ECG device. If an irregularity was detected, trained staff provided support and advice with A-A NHS approved resources for their information. If AF was detected, the participant was given an information form to share with their GP or healthcare professional. Signed consent was sought from each participant to record their data.

Results: During the first half of 2020, A-A and AF Association carried out KYP events across Oxfordshire & Warwickshire, taking 154 pulse rhythm checks. This opportunistic process identified 6 people with AF (3.8%), 10 people with tachycardia (6.5%), 4 people were unclassified (2.6%) and every other pulse check resulted in a normal reading (87.1%). Data collection has been hampered by the COVID-19 pandemic, due to government restrictions regarding lockdown. If restrictions are lifted further data collection will be undertaken later in the year.

Conclusion: Community-based AF awareness events, such as KYP, are an effective opportunistic screening tool to identify people with undiagnosed AF.

References – Can be provided upon request.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72